Production of Banamine Temporarily Halted

Production of the popular anti-inflammatory drug Banamine (flunixin meglumine) and many other drugs manufactured by Schering-Plough Corporation was temporarily halted in May when the manufacturer signed a consent decree of permanent injunction with the Food and Drug Administration (FDA). "FDA found significant violations of the current good manufacturing practices (CGMP) regulations related t

To continue reading this article, become a member of TheHorse.com.

It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.

Sign In
Stay on top of the most recent Horse Health news with FREE weekly newsletters from TheHorse.com. Learn More

Free Newsletters

Sign up for the latest in:

From our partners